Quantcast

Latest RNAi Stories

2014-03-31 20:22:14

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/5wxkx8/global_rna ) has announced the addition of the "Global RNA Interference (RNAi) Therapy Market Outlook 2018" [http://www.researchandmarkets.com/research/5wxkx8/global_rna ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The popularity of RNAi technology has been increasing in recent times as is has become a major...

2014-03-14 08:26:59

WESTBOROUGH, Mass., March 14, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced upcoming presentations at the 6th Ocular Diseases and Drug Development Conference, the 72(nd) Annual Meeting of the American Academy of Dermatology ("AAD") and the Keystone Symposia Meeting, Fibrosis:...

2014-03-13 23:03:47

ReportsnReports.com adds “Global RNA Interference (RNAi) Therapy Market Outlook 2018” reports to its vast collection of research databases. Dallas, Texas (PRWEB) March 13, 2014 The popularity of RNAi technology has been increasing in recent times as it has become a major component of basic research and in drug discovery. Over the years, this technology has become an integral part of the process of determining the functions of genes, in analyzing pathways, and in the validation of the...

2014-03-04 08:31:33

WESTBOROUGH, Mass., March 4, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the 26(th) Annual ROTH Conference on Tuesday, March 11, 2014 at 4:30pm PST. Dr. Cauwenbergh will discuss the development of...

2014-02-24 08:27:38

WESTBOROUGH, Mass., Feb. 24, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the 24(th) Annual Wall Street Analyst Forum on Monday, March 3, 2014 at 12:50pm EST. Dr. Cauwenbergh will discuss the...

2014-01-14 08:28:37

WESTBOROUGH, Mass., Jan. 14, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it received the Notice of Allowance from the United States Patent and Trademark Office on its unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. The patent covers the...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.